Article
Brain Cell-based Genetic Subtyping and Drug Repositioning for Alzheimer Disease
2024-06-21
Abstract excerpt
Alzheimer’s Disease (AD) is characterized by its complex and heterogeneous etiology and gradual progression, leading to high drug failure rates in late-stage clinical trials. In order to better stratify individuals at risk for AD and discern potential therapeutic targets we employed a novel procedure utilizing cell-based co-regulated gene networks and polygenic risk scores (cbPRSs). After defining genetic subtypes...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 89dd1967-195a-5509-806d-8fb3f2e146a1
- DOI
- 10.1101/2024.06.21.24309255
